June 26, 2025 | BeingRareTogether, CLD, CLDSummit, HighHopes, RareDisease, collaboration

Medscape Education is a proud sponsor of the inaugural 2025 Cholestatic Liver Disease Summit, taking place June 26–28 in Aurora, Colorado, at the Hyatt Regency Aurora-Denver Conference Center. Hosted in partnership with Children’s Hospital Colorado, a national leader in cholestatic liver disease treatment and research, this summit represents a powerful step forward for families, clinicians, researchers, and advocates actively working to improve the lives of those affected by rare liver conditions.
This first-of-its-kind event brings together a diverse community focused on rare cholestatic liver diseases. Over three days, the summit will include a Scientific Meeting, Research Roundtable, and a Patient & Family Conference, designed to foster collaboration across disciplines and improve care for rare liver disease communities.
Medscape Education’s sponsorship reflects our deep commitment to supporting underserved and complex disease areas through trusted, evidence-based education. We are especially honored to collaborate with key advocacy organizations, such as the Alagille Syndrome Alliance (ALGSA), Biliary Atresia Research and Education (BARE), and the PFIC Advocacy & Resource Network, Inc., whose efforts continue to drive awareness, research, and hope across these rare conditions.
Rare liver diseases often take 6 to 8 years to be accurately diagnosed. Through education, we aim to help shorten this journey. To support ongoing learning and clinical excellence in rare diseases, we have developed a dedicated learning center for healthcare professionals, created in collaboration with rare disease organizations and leading experts. Our Pathways in Rare Disease initiative is designed to help clinicians recognize the early signs of rare diseases and apply the latest insights in diagnosis and management in clinical practice.
This Summit offers a unique opportunity to bring scientists, clinicians, industry, patients, and families together to bridge knowledge gaps, accelerate research, and build a future of High Hopes for those impacted by cholestatic liver disease. Medscape Education is proud to stand alongside this community as we work together to transform rare disease care through knowledge, compassion, and collaboration.
For more information on this collaboration and future rare disease education, please contact Jennifer Bomberger.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Education has been awarded Accreditation with Commendation, the highest designation possible by the Joint Accreditation for Interprofessional Continuing Education™, ensuring quality accredited continuing education for members of the healthcare...
Spotlight on CLLAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Prof John Gribben, UK, on the most important abstracts to look out for in...
Spotlight on LymphomaAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Dr Loretta Nastoupil, US, on the most important abstracts to look out for in...
A MEDSCAPE DIGITAL HEALTH AND INNOVATION EVENT
The world of medical device technology is constantly evolving. From wearable devices to diagnostic technology, clinicians have more options than ever for monitoring and assessing their patients' health. The accessibility...
Artificial intelligence (AI) is a rapidly growing field with many applications in the world of medicine, including continuing medical education. Ritu Kumar, Medscape lead data scientist, explains how Medscape Education...
For more than 2 years, the COVID-19 pandemic has put emphasis on an issue that has long affected healthcare workers and physicians -- burnout. Every year, Medscape surveys thousands of...
WHAT'S THE STORYStories are shared experiences, where meaning-centered approaches and coping strategies ascribe cultural meaningto events and emotions; a way to merge the individual and the collective experience into the...
EHA2022 Hybrid Congress has now come to a close with the Thematic Days finishing last week. The Medscape team were delighted to connect with so many physicians, colleagues and supporters...
Dr. Hansa Bhargava MD interviews Dr. Maria Victoria Mateos on the most important abstracts to look out for in multiple myeloma and the potential implications of these data for managing patients...
